Biochemical Reagent
-
BA8531 MAO-B-IN-17Summary: MAO-B-IN-17 is a selective monoamine oxidase B inhibitor. -
BA8533 BMS-906024Summary: BMS-906024 is an orally effective, selective gamma secretase inhibitor. -
BA8534 JI051Summary: JI051 is an interaction stabilizer that interacts with the cancer-associated protein chaperone, inhibitin2, to induce cell cycle arrest by inhibiting the downstream effector gene, Hes1. -
BA8535 LY900009Summary: LY900009 is a potent, orally active, signaling inhibitor that acts by selectively inhibiting gamma-secretase proteins. -
BA8536 BMS-983970Summary: BMS-983970 is an orally available inhibitor. -
BA8537 SAHM1Summary: SAHM1 is a dominant-negative MAML form of a peptide mimetic that inhibits the formation of the classical transcription complex. -
BA8541 ASR-490Summary: ASR-490 reduces the viability of HCT116 and SW620 cells by down-regulating signaling. -
BA8542 JI130Summary: JI130 (JI051 derivative) is an interaction stabilizer. -
BA8543 tCFA15Summary: tCFA15 is a trimethylcyclohexene long-chain fatty alcohol. -
BA8544 CitalopramSummary: Citalopram is a racemic mixture containing the active S(+)-enantiomer (Escitalopram; HY-14258) and the R(-)-enantiomer.

